Bridgeway Capital Management’s DexCom DXCM Stock Holding History

Bridgeway Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-27,300	Closed	-$2.55M	–	1372
2023 Q3	$2.55M	Hold	27,300	–	–	0.06%	467
2023 Q2	$3.51M	Hold	27,300	–	–	0.08%	387
2023 Q1	$3.17M	Buy	+27,300	New	+$3.06M	0.08%	388
2021 Q2	–	Sell	-3,200	Closed	-$288K	–	1354
2021 Q1	$288K	Hold	3,200	–	–	0.01%	1236
2020 Q4	$296K	Buy	+3,200	New	+$286K	0.01%	1122
2017 Q1	–	Sell	-237,600	Closed	-$3.55M	–	1405
2016 Q4	$3.55M	Hold	237,600	–	–	0.05%	371
2016 Q3	$5.21M	Hold	237,600	–	–	0.08%	225
2016 Q2	$4.71M	Hold	237,600	–	–	0.07%	249
2016 Q1	$4.03M	Buy	+237,600	New	+$3.97M	0.07%	279

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bridgeway Capital Management's DXCM Position: Q4 2023 in Review

Bridgeway Capital Management sold out of DexCom (DXCM) in Q4 2023, closing a stake of 27,300 shares — an estimated $2.55M sold.

Bridgeway Capital Management first reported a position in DXCM in Q1 2016 and held it in 9 quarters. The position peaked at $5.21M in Q3 2016. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

Bridgeway Capital Management reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
Bridgeway Capital Management sold 27,300 DexCom shares in Q4 2023, an estimated $2.55M.
Bridgeway Capital Management first reported a position in DexCom in Q1 2016 and held it in 9 quarters.
Bridgeway Capital Management's DexCom position peaked at $5.21M in Q3 2016.
975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.